Consequences to patients, clinicians, and manufacturers...

  • Main
  • 2020 / 12
  • Consequences to patients, clinicians, and manufacturers...
EClinicalMedicine 2020 / 12

Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)

Bennett, Charles L., Hoque, Shamia, Olivieri, Nancy, Taylor, Matthew A., Aboulafia, David, Lubaczewski, Courtney, Bennett, Andrew C., Vemula, Jay, Schooley, Benjamin, Witherspoon, Bartlett J., Godwin,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
EClinicalMedicine
DOI:
10.1016/j.eclinm.2020.100693
Date:
December, 2020
File:
PDF, 1.16 MB
2020
Conversion to is in progress
Conversion to is failed